Tender Details

HP02-2025AI Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1/10/2025 to 30 September 2028.

Tender Number:

HP02-2025AI

Awarded Bidder:

ABBVIE-Tel:+27(11)0311600-Email:PV.MEA@abbvie.com.

Region:

Gauteng

Industry:

Healthcare

Title:

HP02-2025AI Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1/10/2025 to 30 September 2028.

Closing Date:

09/09/2024 11:00

Award Date:

21/08/2025 00:00

Tender Description:

Details Tender Number HP02-2025AI Department Health Tender Type Request for Bid(Open-Tender) Province Gauteng Date Published 12/07/2024 Closing Date 09 September 2024 11 00 Place where goods, works or services are required 112 Voortrekker Road-Pretoria Townlands 351-JR,-Pretoria-0186 Special Conditions The Special Conditions of Contract is included in the bid pack. All potential bidders should read these conditions carefully as several changes were implemented. it is also advised that all potential bidders should attend the non-compulsory briefing session by registering to attend the webinar with the link provided. ENQUIRIES Contact Person Mandie Coetzee Email mandie.coetzee@health.gov.za Telephone number 012-395-8419 FAX Number N/A BRIEFING SESSION Is there a briefing session? Yes Is it compulsory? No Briefing Date and Time 02/08/2024 10 00 Briefing Venue https //events.teams.microsoft.com/event/c3ce39a2-476c-4677-b7c4-e255606f462c@a517371c-f316-484c-ac5 TENDER DOCUMENTS 4. HP02-2025AI_PBD9 Directors Categorisation_12/07/2024.xlsx 5. HP02-2025AI_Final BidResp_12/07/2024 BS.xlsx 2. HP02-2025AI_Bid Pack Final_12/07/2024.pdf 3. HP02-2025AI_Annexure A_Final_12/07/2024.xlsx 1. HP02-2025AI__Invitation to bid_ notice_for NDOH website_12/07/2024.pdf

Amount R1 230 874,51

Bidders R842 790,00

HP02-2025AI: Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2025 to 30 September 2028.